Cargando…

Molecular Mechanisms of NAFLD in Metabolic Syndrome

Detalles Bibliográficos
Autores principales:	Martins, Maria João, Ascensão, António, Magalhães, José, Collado, Maria Carmen, Portincasa, Piero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452820/ https://www.ncbi.nlm.nih.gov/pubmed/26078958 http://dx.doi.org/10.1155/2015/621080

Ejemplares similares

NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
por: Portincasa, Piero
Publicado: (2023)

Correction to: NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
por: Portincasa, Piero
Publicado: (2023)

Intestinal Barrier and Permeability in Health, Obesity and NAFLD
por: Portincasa, Piero, et al.
Publicado: (2021)

NAFLD - A rising metabolic disease
por: Zeigerer, Anja
Publicado: (2021)

NAFLD: From Mechanisms to Therapeutic Approaches
por: Gariani, Karim, et al.
Publicado: (2022)

The Link between NAFLD and Metabolic Syndrome
por: Radu, Fabiana, et al.
Publicado: (2023)

Relevance of a Hypersaline Sodium-Rich Naturally Sparkling Mineral Water to the Protection against Metabolic Syndrome Induction in Fructose-Fed Sprague-Dawley Rats: A Biochemical, Metabolic, and Redox Approach
por: Pereira, Cidália Dionísio, et al.
Publicado: (2014)

Mitochondria in Health and Disease
por: Magalhães, José, et al.
Publicado: (2014)

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
por: Di Ciaula, Agostino, et al.
Publicado: (2021)

Interactions between Bile Acids and Nuclear Receptors and Their Effects on Lipid Metabolism and Liver Diseases
por: Wang, David Q.-H., et al.
Publicado: (2012)

Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
por: Rizvi, Ali Abbas, et al.
Publicado: (2021)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD
por: Mavromati, Maria, et al.
Publicado: (2021)

Molecular Interactions between NAFLD and Xenobiotic Metabolism
por: Naik, Adviti, et al.
Publicado: (2013)

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
por: Recuero, Amanda Medeiros, et al.
Publicado: (2022)

Is Metabolic Syndrome Useful for Identifying Youths with Obesity at Risk for NAFLD?
por: Di Bonito, Procolo, et al.
Publicado: (2023)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Molecular Advances in Microbial Metabolism
por: Martínez-Espinosa, Rosa María, et al.
Publicado: (2023)

The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Stachowska, Ewa, et al.
Publicado: (2020)

NAFLD: Is There Anything New under the Sun?
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease
por: Stevanović, Jelena, et al.
Publicado: (2019)

From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2014)

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
por: Michelotti, Anna, et al.
Publicado: (2021)

Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD
por: Sanchez, Jessica I., et al.
Publicado: (2023)

Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study
por: Montemayor, Sofía, et al.
Publicado: (2022)

Lean NAFLD: A not so benign condition?
por: VanWagner, Lisa B., et al.
Publicado: (2018)

Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome
por: Wang, Helen H., et al.
Publicado: (2020)

Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives
por: Fotis, Dimitrios, et al.
Publicado: (2022)

PPARs and Mitochondrial Metabolism: From NAFLD to HCC
por: Mello, Tommaso, et al.
Publicado: (2016)

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
por: Wainwright, Patrick, et al.
Publicado: (2016)

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
por: Godoy-Matos, Amélio F., et al.
Publicado: (2020)

Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLD
por: Duvnjak, Marko, et al.
Publicado: (2019)

Staging NAFLD: Diagnostic and Therapeutic Value of TAM Signaling
por: Cubero, Francisco Javier
Publicado: (2019)

Is the Mediterranean Diet the Best Approach to NAFLD Treatment Today?
por: Angelico, Francesco, et al.
Publicado: (2021)

The heated debate over NAFLD renaming: An ongoing saga
por: Yilmaz, Yusuf
Publicado: (2023)

The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD
por: Östlund, Cecilia, et al.
Publicado: (2020)

Comorbidities and Metabolic Derangement of NAFLD
por: Bang, Ki Bae, et al.
Publicado: (2015)

Metabolic Changes of Hepatocytes in NAFLD
por: Lu, Qianrang, et al.
Publicado: (2021)

Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
por: Vairetti, Mariapia, et al.
Publicado: (2022)

Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests
por: Di Ciaula, Agostino, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n6cjtnjjiqlk12mn2o9tq71jja